We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. should postpone second doses of the Pfizer/BioNTech COVID-19 vaccine in order to conserve supply and inoculate as many people as possible, two Canadian researchers recommended, citing data showing the initial dose to be highly effective. Read More
The EU yesterday unveiled a plan to speed up regulatory approvals and manufacturing of vaccines against emerging strains of the SARS-CoV-2 virus that causes COVID-19. Read More
Created by the prior administration to accelerate development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics, Operation Warp Speed (OWS) is an initiative in search of a new name, but it already has a new lineup of prominent individuals chosen by the Biden administration, including a new front man, Jeffrey Zients. Read More
The EU has struck new supply agreements with Moderna and Pfizer, boosting its total COVID-19 vaccine arsenal to up to 2.6 billion doses, enough to inoculate the bloc’s 446 million citizen many times over, but it is promising to share with “neighbors and partners.” Read More
A specially convened UK clinical trial ethics committee has given the go-ahead for a COVID-19 human challenge study that is slated to start within weeks to help inform further vaccine and treatment research. Read More
Moderna announced that it expects to deliver its second batch of 100 million COVID-19 vaccine doses to the U.S. government faster than expected, with the shipment now set to be completed by the end of May. Read More
The World Health Organization (WHO)’s COVAX initiative is set to begin distributing vaccines to low- and middle-income nations this month, following the organization’s approval of an emergency-use listing of the AstraZeneca (AZ)/Oxford vaccine. Read More
The European Medicines Agency (EMA) is now reviewing Johnson & Johnson’s (J&J) conditional marketing authorization application for its COVID-19 vaccine, a single-dose inoculation that would help to simplify the EU’s vaccination efforts. Read More
Efforts to reach large-scale production of a COVID-19 vaccine modified to address new viral variants could take AstraZeneca (AZ) at least six months to achieve, according to company documents. Read More
Roche’s anti-inflammatory drug Actemra (tocilizumab) has been shown to reduce COVID-19-related deaths in the UK’s RECOVERY trial of multiple potential treatments. Read More